Affirm's Blockbuster Growth Still Has Legs - Premium Already Baked-In

Affirm's Blockbuster Growth Still Has Legs - Premium Already Baked-In

Offline retail through Affirm Card, new verticals across professional services/elective medical, and international expansion underscore AFRM's multi-pronged growth strategy. These have fed into the expanding merchant base, growing funding capacity, strong Affirm Card adoption, and higher transaction frequencies. AFRM's conservative FY2027 guidance may be revised upwards, as observed in the thrice raised FY2026 guidance and robust GMV growth. Despite the compelling valuation metrics, strong FCF, and healthier balance sheet, momentum fatigue and insider selling suggest limited near-term upside potential. AFRM is downgraded to Hold after the overly done Q2'26 rally, with further volatility likely, pending the normalization in macroeconomic environment.

I previously rated Affirm ( AFRM ) as a Buy in May 2026, thanks to their profitable growth prospects. In this article, I shall discuss why AFRM has been downgraded as a Hold, attributed to the overly done Q2'26